Kimberly Mackey, MD
Neurological Surgery · Albuquerque, NMNPI 1952533739
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,273 of the $1,406 with a category attached, or 90.5%. Stryker accounts for 79.6% of it on its own, with 5 other manufacturers making up the rest. 2025 is the largest year on record at $1,137, more than ten times the $16 reported in 2022. That places this record below the midpoint for neurological surgery clinicians in NM, where the typical reported total is $2,209.
Across 14 payments — averaging $100.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$1K
- Arthrex$205
- CGG Medical Inc$28
- Evoke Pharma, Inc.$21
- Pacira Pharmaceuticals Incorporated$17
- KCI USA, Inc.$16
What the payments were for
- Travel & lodging$1,27391%
- Food & beverage$1339%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 7 | $1,119 |
| Arthrex | 3 | $205 |
| CGG Medical Inc | 1 | $28 |
| Evoke Pharma, Inc. | 1 | $21 |
| Pacira Pharmaceuticals Incorporated | 1 | $17 |
| KCI USA, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MAKO$1,112
How this compares
$1,406 in reported general payments places this provider in the 40th percentile of 32 neurological surgery providers in New Mexico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 23 | $304 |
| Tizanidine Hcl | 33 | $258 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 40 | $250 |
| Cyclobenzaprine Hcl | 26 | $204 |
| Methylprednisolone | 29 | $203 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 70 | $198 |
| Ibuprofen | 27 | $90 |
| Famotidine | 11 | $66 |
| Meloxicam | 11 | $54 |
| Tramadol Hcl | 14 | $49 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in Albuquerque
- Chad ColeAlbuquerque$101K
- Robert StarlingAlbuquerque$13K
- Christian RicksAlbuquerque$12K
- Michael KoganAlbuquerque$10K
- Peter ShinAlbuquerque$8K
- Ross GreenAlbuquerque$6K
- Mark ErasmusAlbuquerque$5K
- Mark BryniarskiAlbuquerque$4K
- Michael Ortiz TorresAlbuquerque$4K
- Carlos AlvarezAlbuquerque$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.